20
thousand+
well done operations using Normacor solution
20
+ centers
use the solution during operations
1 000
+ cases
enrolled in the patient registry
13
countries
Normacor cardioplegia patents were obtained in Europe, Asia, and America
8
original clinical trials
2
trials approved by the Russian Ministry of Health
12
+
publications in Russian and international journals
0
adverse reactions in the pharmacovigilance national database
A solution with proven safety and efficacy
Evidence based
Cardiac protection under normothermia conditions
About the solution
No reperfusion injury
For operations of any complexity
Self-restoration of rhythm
NORMACOR was developed in collaboration with the ChemRar Group as an open-heart medicine in normothermic conditions.
The drug contains an effective formula of components that allows for surgery under normothermia and moderate hypothermia. It virtually eliminates ischemia and reperfusion injury, providing a high degree of myocardial protection during any type and comlexity of surgery.
SOLUTION NO. 1
High-potassium
Used for rapid induction of asystole at the beginning of the operation. It makes sure that the cardiac arrest is controlled and predictable.
SOLUTION NO. 2
Low-potassium
Used for maintenance of asystole phase. Provides stable myocardial protection throughout the entire surgery.
Cardioplegia delivery systems design options
CSP Perfusion sets
Available in five variants: for blood and crystalloid cardioplegia, with usage of one or two solutions and perfusate thermoregulation.
Variations of Perfusion sets
Cardio System Pharma
CSP.1
Compatible with Normacor
Compatible with Normacor
Blood · normal/moderate hypothermia · up to 2 solutions
CSP.2
Blood · hypothermic · 2 solutions
CSP.3
Compatible with Normacor
Compatible with Normacor
Blood · normal/moderate hypothermia · 1 solution
CSP.6
Crystalloid · 1 solution
CSP.4
Crystalloid · up to 2 solutions
Characteristics of the CSP delivery systems | Perfusion sets
Structure of delivery systems
Each component is designed for safety—from the air trap to the universal connectors for the oxygenator. Select an option to view its components.
Three-way valve
removes air from circuit
Y-connector
connects the blood and cardioplegia solution circuits
Silicone tubes
connect to roller pumps
Double-channel polymer needles
firm connection to cardioplegia containers
1/4" connector
connects to an oxygenator
Air Trap
safely eliminates air bubbles out of the fluid
CSP.1
Three-way valve
removes air from circuit
Heat exchanger
cools the perfusate
Silicone tubes
connect to roller pumps
Double-channel polymer needles
firm connection to cardioplegia containers
1/4" connector
connects to an oxygenator
Air Trap
safely eliminates air bubbles out of the fluid
CSP.2
Three-way valve
removes air from circuit
Y-connector
connects the blood and cardioplegia solution circuits
Silicone tubes
connect to roller pumps
Double-channel polymer needle
firm connection to a cardioplegia container
1/4" connector
для подключения к оксигенатору
Air Trap
safely eliminates air bubbles out of the fluid
CSP.3
Three-way valve
removes air from circuit
Luer ML
connects to a cardioplegic cannula
Silicone tube
connects to a roller pump
Double-channel polymer needles
firm connection to cardioplegia containers
Invasive pressure monitoring line
Air Trap
safely eliminates air bubbles out of the fluid
CSP.4
Three-way valve
removes air from circuit
Luer ML
connects to a cardioplegic cannula
Silicone tube
connects to a roller pump
Double-channel polymer needle
firm connection to a cardioplegia container
Invasive pressure monitoring line
Air Trap
safely eliminates air bubbles out of the fluid
CSP.6
JSC "CARDIOSYSTEMPHARMA"
Owner LP-No.(015032)-(RG-RU)
Owner LP-No.(015032)-(RG-RU)
2a-1, Rabochaya, St. Khimki, Moscow Region, 141401 Russia
© 2026 АО «КардиоСистемФарма». Все права защищены.
Мы используем куки для работы сайта